460 related articles for article (PubMed ID: 35068796)
1. A Current Understanding of Bile Acids in Chronic Liver Disease.
Farooqui N; Elhence A; Shalimar
J Clin Exp Hepatol; 2022; 12(1):155-173. PubMed ID: 35068796
[TBL] [Abstract][Full Text] [Related]
2. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
3. Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases.
Sanyal AJ; Ling L; Beuers U; DePaoli AM; Lieu HD; Harrison SA; Hirschfield GM
JHEP Rep; 2021 Jun; 3(3):100255. PubMed ID: 33898959
[TBL] [Abstract][Full Text] [Related]
4. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
5. Bile acids are nutrient signaling hormones.
Zhou H; Hylemon PB
Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
[TBL] [Abstract][Full Text] [Related]
6. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
7. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
8. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
Manley S; Ding W
Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
[TBL] [Abstract][Full Text] [Related]
9. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
10. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
[TBL] [Abstract][Full Text] [Related]
11. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
Kwong E; Li Y; Hylemon PB; Zhou H
Acta Pharm Sin B; 2015 Mar; 5(2):151-7. PubMed ID: 26579441
[TBL] [Abstract][Full Text] [Related]
12. Bile acid homeostasis in female mice deficient in
Rizzolo D; Kong B; Taylor RE; Brinker A; Goedken M; Buckley B; Guo GL
Acta Pharm Sin B; 2021 Dec; 11(12):3847-3856. PubMed ID: 35024311
[TBL] [Abstract][Full Text] [Related]
13. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
[TBL] [Abstract][Full Text] [Related]
14. Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism.
Zhang Y; Csanaky IL; Selwyn FP; Lehman-McKeeman LD; Klaassen CD
Biochem Pharmacol; 2013 Aug; 86(3):437-45. PubMed ID: 23747753
[TBL] [Abstract][Full Text] [Related]
15. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
[TBL] [Abstract][Full Text] [Related]
16. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids.
Ferrebee CB; Dawson PA
Acta Pharm Sin B; 2015 Mar; 5(2):129-34. PubMed ID: 26579438
[TBL] [Abstract][Full Text] [Related]
18. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
[TBL] [Abstract][Full Text] [Related]
19. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics.
Ridlon JM; Bajaj JS
Acta Pharm Sin B; 2015 Mar; 5(2):99-105. PubMed ID: 26579434
[TBL] [Abstract][Full Text] [Related]
20. Obeticholic acid-a new therapy in PBC and NASH.
Chapman RW; Lynch KD
Br Med Bull; 2020 May; 133(1):95-104. PubMed ID: 32282030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
